Citigroup »

Janux Therapeutics shares owned by Citigroup

Quarter-by-quarter ownership of Janux Therapeutics (JANX) shares owned by Citigroup from 13F filings

Historical chart of Citigroup investment in Janux Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Janux Therapeutics held by Citigroup consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Janux Therapeutics by Citigroup

Quarter filed Position value Share count Share price at filing
2024-09-30 $976k 22k 45.44
2024-06-30 $652k 16k 41.83
2024-03-31 $1.6M 42k 37.67
2023-12-31 $41k 3.8k 10.71
2023-09-30 $4.9k 490 10.00
2023-03-31 $6.8k 559 12.10
2022-12-31 $5.2k 397 13.17
2022-09-30 $13k 985 13.20
2021-12-31 $94k 4.8k 19.65